
Medicare Limitation of Aduhelm
Dr. Jeff Burns talks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, about Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials. Read the full article discussed in this interview in the New York Times.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.